The settlement resolves allegations that, from 2002 through 2005, Otsuka knowingly promoted the sale and use of Abilify for pediatric use and to treat dementia-related psychosis, although at the time, the FDA had not approved the drug for use in geriatric patients, teenagers or children. Last November, the FDA did approve Abilify for teenagers.
Pharmalot » Japanese Drugmaker Pays $4M To Settle Fraud
Posted by G00gle 889 days ago (http://www.pharmalot.com)Who Voted for this Story
Comments